The chemotherapy of colon cancer
Authors:
- R DuncanRDR Duncan
- R.J KnoxRKR.J Knox
- 1 July 1995
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 31 (7-8) , 1373-1378
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antibody-Directed Enzyme Prodrug TherapyClinical Immunotherapeutics, 1995
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal of Cancer, 1995
- Polymer ConjugatesClinical Pharmacokinetics, 1994
- Poly (ortho ester) matrices for controlled release of the antitumour agent 5-fluorouracilJournal of Controlled Release, 1994
- New Tumor Suppressor May Rival p53Science, 1994
- Cyclins and oncogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- Polymeric Drug-Carriers Containing Doxorubicin and Melanocyte-Stimulating Hormone:In VitroandIn VivoEvaluation Against Murine MelanomaJournal of Drug Targeting, 1993
- Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymersJournal of Controlled Release, 1991
- Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineCancer Immunology, Immunotherapy, 1990
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989